InnovaRx Innova Health Strategies

Q56.4

Indeterminate sex, unspecified

Billable FY2026 2025-10-01 → 2026-09-30
This is the unspecified option. 4 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.
Exclusions 8 never code together
Q56code
Excludes1
  • 46,XX true hermaphrodite (Q99.1)Q99.1
  • androgen insensitivity syndrome (E34.5-)E34.5-
  • chimera 46,XX/46,XY true hermaphrodite (Q99.0)Q99.0
  • female pseudohermaphroditism with adrenocortical disorder (E25.-)E25.-
  • pseudohermaphroditism with specified chromosomal anomaly (Q96-Q99)Q96-Q99
  • pure gonadal dysgenesis (Q99.1)Q99.1
Q50-Q56block
Excludes1
  • androgen insensitivity syndrome (E34.5-)E34.5-
  • syndromes associated with anomalies in the number and form of chromosomes (Q90-Q99)Q90-Q99

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 1
Q56.4code
Inclusion terms
  • Ambiguous genitalia
Index entries leading here 2
  • Ambiguous genitalia Q56.4
  • Indeterminate sex Q56.4
Alongside this code 4 same parent — Q56
Medications 1

MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.

Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
Q56
Block
Q50-Q56
Siblings
4

Present FY2024–FY2027.